Monday, June 4, 2012

Drug Makers Vowed To Campaign For Health Law, Memos Show

Bloomberg has;

Drug Makers Vowed To Campaign For Health Law, Memos Show

By Drew Armstrong - May 31, 2012 2:51 PM ET

Drugmakers led by Pfizer (PFE) Inc. agreed to run a “very significant public campaign” bankrolling political support for the 2010 health-care law, including TV ads, while the Obama administration promised to block provisions opposed by drugmakers, documents released by Republicans show.
The internal memos and e-mails for the first time unveil the industry's plan to finance positive TV ads and supportive groups, along with providing $80 billion in discounts and taxes that were included in the law. The administration has previously denied the existence of a deal involving political support.
The documents were released today by Republicans on the House Energy and Commerce Committee. They identify price controls under Medicare and drug importation as the key industry concerns, and show that former Pfizer Chief Executive Officer Jeffrey Kindler and his top aides were involved in drawing it up and getting support from other company executives.
Thank You Bloomberg and Mr Armstrong

What did you expect? The more we learn of PPACA the more we learn that the Drug Companies, along with the President's party, were the intended beneficiaries. 


Daniel Haszard said...

Hoping the tide of Risperdal outrage becomes even stronger.

It needs to include all the children being given these drugs for bogus reasons – many children in foster care, or with the fake diagnosis of “pediatric bipolar”, and etc., etc. Pick up any magazine (especially women’s magazines) and there are ads for “if your antidepresant isn’t working, just add Abilify”. No mention of why a person would continue to take a non-working anti-depressant, let alone add one of the atypicals, a drug class that should really never have been.
*tell the truth don't be afraid* Daniel Haszard FMI

D Bunker said...

Risperdal, Zyprexa, Seroquel, All of the Anti depressants, ....... None of it should be on the market.